The active ingredient, liraglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist
This set is specifically designed to tackle the "big three" eye concerns: dark circles, dullness, and fine lines
slowed gastric emptying (gastroparesis) GLP-1 agonists stimulate GLP-1 receptors in the CNS including vagal efferent fibers in the brainstem
Anti-Inflammatory Activity Several experimental studies have observed reduced inflammatory signaling in gut tissue following administration of BPC-157
Ghiasi P, Hosseinkhani S, Noori A, Nafissi S, Khajeh K
3.3.2 The comparison of urinary AKI biomarkers between two groups According to statistical results, it showed that mean SD of NGAL after treatment were 138.4 82.3, 107.6 42.0 in RG group and RG + CHF group respectively